documents: FDA-2002-N-0194-0002
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2002-N-0194-0002 | FDA | FDA-2002-N-0194 | Agency Information Collection Activities; Submission for OMB Review; Comment Request; New Drug and Biological Drug Products; Evidence Needed to Demonstrate Effectiveness of New Drugs When Human Efficacy Studies Are Not Ethical or Feasible | Notice | General Notice | 2003-03-16T05:00:00Z | 2003 | 3 | 2003-03-07T05:00:00Z | 2003-04-08T03:59:59Z | 2025-05-13T09:45:34Z | 03-5357 | 0 | 0 | 0900006480495892 |
Links from other tables
- 1 row from regs_document_id in fr_regs_crossref